Showing results (491-500 of 532) with videos related to
Sort By:
Pageof 54
Blood|April 14, 2010
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myelomaPaul G Richardson, Edie Weller, Sagar Lonial, et al.Cell Reports|April 6, 2017
The Mutational Landscape of Circulating Tumor Cells in Multiple MyelomaYuji Mishima, Bruno Paiva, Jiantao Shi, et al.Cell|September 6, 2011
BET bromodomain inhibition as a therapeutic strategy to target c-MycJake E Delmore, Ghayas C Issa, Madeleine E Lemieux, et al.Blood|January 17, 2014
A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myelomaPaul G Richardson, Wanling Xie, Sundar Jagannath, et al.Nature|May 8, 2024
Mapping genotypes to chromatin accessibility profiles in single cellsFranco Izzo, Robert M Myers, Saravanan Ganesan, et al.American Journal of Hematology|August 29, 2019
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myelomaIrene M Ghobrial, Chia-Jen Liu, Oksana Zavidij, et al.Blood|November 21, 2024
Serum free light chains in a racially diverse population including African Americans and populations from South AfricaLuca Bertamini, Jean-Baptiste Alberge, David J Lee, et al.Nature Communications|June 15, 2022
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomesMark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2019
Progression Risk Stratification of Asymptomatic Waldenström MacroglobulinemiaMark Bustoros, Romanos Sklavenitis-Pistofidis, Prashant Kapoor, et al.Nature Cancer|January 7, 2021
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myelomaOksana Zavidij, Nicholas J Haradhvala, Tarek H Mouhieddine, et al.Pageof 54